RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Chongqing Zhifei Biological Products Co - Stock

Chongqing Zhifei Biological Products Co Liabilities 2024

Chongqing Zhifei Biological Products Co Liabilities

18.73 B CNY

Ticker

300122.SZ

ISIN

CNE100000V20

In 2024, Chongqing Zhifei Biological Products Co's total liabilities amounted to 18.73 B CNY, a 36.02% difference from the 13.77 B CNY total liabilities in the previous year.

Chongqing Zhifei Biological Products Co Aktienanalyse

What does Chongqing Zhifei Biological Products Co do?

Chongqing Zhifei Biological Products Co Ltd is a Chinese company that was founded in 1998 and is headquartered in Chongqing, China. The company operates in the biotechnology sector and focuses on the research, development, and manufacturing of biological products. The company initially started in the 1990s as a small laboratory unit of Chongqing Lummy Pharmaceutical Co Ltd, a Chinese pharmaceutical company that mainly produced drugs. In 1998, the company decided to focus on the business of biological products and established Chongqing Zhifei Biological Products Co Ltd. The company's business model is based on the production of high-quality biopharmaceuticals and medical devices. Zhifei Biological Products offers a wide range of products such as vaccines, blood products, virus tests, medical devices, and diagnostic kits. The company has four main business fields: vaccines, blood products, test kits, and medical devices. Among vaccines, Zhifei Biological Products offers a range of vaccines for the prevention of infectious diseases such as hepatitis B, diphtheria, tetanus, and pertussis. The blood products manufactured by the company include intravenous immunoglobulins, plasma proteins, and albumin. Test kits include IgG antibody tests and quantitative PCR tests. Additionally, the company also offers a wide range of medical devices including blood collection kits, syringes, and infusion sets. The company has established itself in China as a trusted and reliable manufacturer of biopharmaceuticals and collaborates closely with various healthcare organizations to promote the prevention and control of infectious diseases. Zhifei Biological Products has also successfully exported its products to other countries and is active in the international market. In recent years, Zhifei Biological Products has also played a crucial role in the fight against the COVID-19 pandemic. The company, in collaboration with the Chinese military, developed and produced a COVID-19 vaccine in a short period of time. This vaccine has already been approved in countries such as Indonesia and Brazil and is being distributed worldwide. The company takes pride in not only manufacturing biopharmaceuticals but also contributing to creating a better world. It has a strong corporate culture and constantly promotes innovation and advanced technology. Chongqing Zhifei Biological Products Co Ltd is a key player in the Chinese biotechnology industry and plays an important role in improving global health. Chongqing Zhifei Biological Products Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Chongqing Zhifei Biological Products Co's Liabilities

Chongqing Zhifei Biological Products Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Chongqing Zhifei Biological Products Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Chongqing Zhifei Biological Products Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Chongqing Zhifei Biological Products Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Chongqing Zhifei Biological Products Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Chongqing Zhifei Biological Products Co Stock

What is the level of liabilities of Chongqing Zhifei Biological Products Co this year?

Chongqing Zhifei Biological Products Co has a debt balance of 18.73 B CNY this year.

What were the liabilities of Chongqing Zhifei Biological Products Co compared to the previous year?

The liabilities of Chongqing Zhifei Biological Products Co have increased by 36.02% increased compared to the previous year.

What are the consequences of high debt for investors of Chongqing Zhifei Biological Products Co?

High liabilities can pose a risk for investors of Chongqing Zhifei Biological Products Co, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Chongqing Zhifei Biological Products Co?

Low liabilities mean that Chongqing Zhifei Biological Products Co has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Chongqing Zhifei Biological Products Co affect the company?

An increase in liabilities of Chongqing Zhifei Biological Products Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Chongqing Zhifei Biological Products Co affect the company?

A decrease in the liabilities of Chongqing Zhifei Biological Products Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Chongqing Zhifei Biological Products Co?

Some factors that can influence the liabilities of Chongqing Zhifei Biological Products Co include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Chongqing Zhifei Biological Products Co so important for investors?

The liabilities of Chongqing Zhifei Biological Products Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Chongqing Zhifei Biological Products Co take to modify the liabilities?

To change its liabilities, Chongqing Zhifei Biological Products Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Chongqing Zhifei Biological Products Co pay?

Over the past 12 months, Chongqing Zhifei Biological Products Co paid a dividend of 0.33 CNY . This corresponds to a dividend yield of about 1.15 %. For the coming 12 months, Chongqing Zhifei Biological Products Co is expected to pay a dividend of 0.42 CNY.

What is the dividend yield of Chongqing Zhifei Biological Products Co?

The current dividend yield of Chongqing Zhifei Biological Products Co is 1.15 %.

When does Chongqing Zhifei Biological Products Co pay dividends?

Chongqing Zhifei Biological Products Co pays a quarterly dividend. This is distributed in the months of September, September, August, July.

How secure is the dividend of Chongqing Zhifei Biological Products Co?

Chongqing Zhifei Biological Products Co paid dividends every year for the past 16 years.

What is the dividend of Chongqing Zhifei Biological Products Co?

For the upcoming 12 months, dividends amounting to 0.42 CNY are expected. This corresponds to a dividend yield of 1.44 %.

In which sector is Chongqing Zhifei Biological Products Co located?

Chongqing Zhifei Biological Products Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Chongqing Zhifei Biological Products Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chongqing Zhifei Biological Products Co from 6/16/2023 amounting to 0.333 CNY, you needed to have the stock in your portfolio before the ex-date on 6/16/2023.

When did Chongqing Zhifei Biological Products Co pay the last dividend?

The last dividend was paid out on 6/16/2023.

What was the dividend of Chongqing Zhifei Biological Products Co in the year 2023?

In the year 2023, Chongqing Zhifei Biological Products Co distributed 0.6 CNY as dividends.

In which currency does Chongqing Zhifei Biological Products Co pay out the dividend?

The dividends of Chongqing Zhifei Biological Products Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Chongqing Zhifei Biological Products Co

Our stock analysis for Chongqing Zhifei Biological Products Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chongqing Zhifei Biological Products Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.